Stocks and Investing
Stocks and Investing
Thu, December 28, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, December 27, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, December 26, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Jason Zemansky Downgraded (ALVR) to Sell and Decreased Target to $1 on, Dec 26th, 2023
Jason Zemansky of B of A Securities, Downgraded "AlloVir, Inc." (ALVR) to Sell and Decreased Target from $17 to $1 on, Dec 26th, 2023.
Jason has made no other calls on ALVR in the last 4 months.
There are 3 other peers that have a rating on ALVR. Out of the 3 peers that are also analyzing ALVR, 2 agree with Jason's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Christopher Raymond of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $1.5 on, Friday, December 22nd, 2023
- Mani Foroohar of "Leerink Partners" Downgraded from Buy to Hold and Held Target at $1 on, Friday, December 22nd, 2023
This is the rating of the analyst that currently disagrees with Jason
- Anupam Rama of "JP Morgan" Downgraded from Buy to Sell on, Friday, December 22nd, 2023
Contributing Sources